Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Stuart Martin, PhD

University of Maryland School of Medicine

Presented In Memory of Wendy Taylor by Northwest Arkansas Metsquerade

Reducing the risk of chemotherapy-induced scattering of metastatic triple-negative breast tumors

Stuart S. Martin, PhD

University of Maryland, Baltimore

Presented in memory of Kerry O’Riordan McAdam and in honor of Jacqueline Beck

Leveraging combined ctDNA and CTC analysis to optimize treatment for existing bone metastases

Stuart Martin, PhD

University of Maryland School of Medicine

Presented by the We “Neeta” Cure Fundraiser in Memory of Neta Meier

Targeting Tau-induced microtubule stabilization to reduce outgrowth of metastatic tumors

Julie Di Martino, PhD

Icahn School of Medicine at Mount Sinai

Targeting dormant breast cancer cells with ACE inhibitors

Andrea M. Mastro, PhD

The Pennsylvania State University

Dormancy or growth? A three dimensional in vitro system to study breast cancer metastases in bone

Sandra McAllister, PhD

Brigham and Women’s Hospital; Harvard Medical School

Presented In Memory of Lauren Smoke by Chicago Metsquerade

A new approach to identifying effective therapeutic strategies that eliminate de novo and recurrent stage IV triple-negative bre

ELIZABETH MCDONALD, MD, PhD

University of Pennsylvania

In vivo visualization and quantification of pharmacodynamics response to PARPi therapy

Kathleen McEnnis, PhD

New Jersey Institute of Technology

Presented by #LightUpMBC Ambassadors in memory of Nola Addante and all lives lost too soon to MBC

Mesenchymal stem cells as platinum nanoparticle delivery system for metastatic breast cancer treatment

Chris McGinnis, PhD

Stanford University School of Medicine

Presented in memory of Amy Verrill Wolfe, MJ Borrelli, members of DENJPA | ALSO Presented by the Family of Erica Griffiths, in her memory

Discovering Anti-Metastatic Immunotherapies and Mechanisms of Secondary Metastatic Dissemination

JAMES MCINTYRE, MA, PhD AND BARBARA FINGLETON, PhD

Vanderbilt University

A Novel Self-Reporting Paclitaxel Prodrug without Systemic Neurotoxicity: Preclinical Assessment for Targeted Treatment of Metas

Efi Kokkotou MD, PhD

Beth Israel Deaconess Medical Center

Presented by Minneapolis Metsquerade in memory of Kim Cesarek

Development of a functional predictor assay of therapeutic responses in Metastatic Breast Cancer

Melanie Hayden Gephart MD, MAS

Stanford University

Presented by Be Bold and Behold in loving memory of honorees Jennie Byram and Erica Griffiths

Halting the Progression of Breast Cancer Brain Metastases By Targeting Tumor-Associated Microglia (TAMs)